Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$880K Sell
7,759
-430
-5% -$42.6K 0.01% 706
2026
Q1
$771K Sell
8,189
-1,209
-13% -$121K 0.01% 732
2025
Q4
$930K Sell
9,398
-919
-9% -$88.9K 0.01% 638
2025
Q3
$875K Sell
10,317
-250
-2% -$19.8K 0.01% 659
2025
Q2
$720K Sell
10,567
-679
-6% -$43K 0.01% 716
2025
Q1
$681K Sell
11,246
-2,926
-21% -$204K 0.01% 696
2024
Q4
$972K Sell
14,172
-204
-1% -$14.5K 0.01% 590
2024
Q3
$978K Buy
14,376
+259
+2% +$16.5K 0.01% 578
2024
Q2
$859K Buy
14,117
+9,183
+186% +$520K 0.01% 575
2024
Q1
$281K Buy
+4,934
New +$296K 0.01% 547

Other funds holding INCY

Choreo LLC's INCY Position: Q2 2026 in Review

Choreo LLC reduced its Incyte (INCY) stake by 5.3% in Q2 2026, selling an estimated $42.6K and leaving 7,759 shares worth $880K. The position accounts for 0.01% of the portfolio, ranked #706.

Choreo LLC first reported a position in INCY in Q1 2024 and has held it in 10 quarters since. The position peaked at $978K in Q3 2024. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Choreo LLC held 7,759 shares of Incyte worth $880K as of Q2 2026.
  • Choreo LLC sold 430 Incyte shares in Q2 2026, an estimated $42.6K.
  • Incyte made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #706 holding.
  • Choreo LLC first reported a position in Incyte in Q1 2024 and has held it in 10 quarters since.
  • Choreo LLC's Incyte position peaked at $978K in Q3 2024.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.